Globus Medical Inc (NYSE: GMED) is -11.33% lower on its value in year-to-date trading and has touched a low of $49.33 and a high of $94.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GMED stock was last observed hovering at around $71.59 in the last trading session, with the day’s gains setting it 1.75%.
Currently trading at $73.34, the stock is -4.19% and -12.67% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.25 million and changing 2.44% at the moment leaves the stock -3.91% off its SMA200. GMED registered 42.68% gain for a year compared to 6-month gain of 4.82%. The firm has a 50-day simple moving average (SMA 50) of $83.9822 and a 200-day simple moving average (SMA200) of $76.321.
The stock witnessed a -13.54% loss in the last 1 month and extending the period to 3 months gives it a -11.02%, and is 2.86% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.08% over the week and 2.95% over the month.
Globus Medical Inc (GMED) has around 5300 employees, a market worth around $11.73B and $2.52B in sales. Current P/E ratio is 98.52 and Fwd P/E is 18.50. Profit margin for the company is 4.09%. Distance from 52-week low is 48.67% and -22.74% from its 52-week high. The company has generated returns on investments over the last 12 months (2.42%).
with sales reaching $631.09M over the same period.The EPS is expected to grow by 9.79% this year, but quarterly earnings will post 6.40% year-over-year. Quarterly sales are estimated to grow 4.03% in year-over-year returns.
664.0 institutions hold shares in Globus Medical Inc (GMED), with institutional investors hold 82.36% of the company’s shares. The shares outstanding are 114.99M, and float is at 113.96M with Short Float at 2.30%. Institutions hold 81.85% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 10.67 million shares valued at $$731.06 million. The investor’s holdings represent 7.8857 of the GMED Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 10.34 million shares valued at $$708.18 million to account for 7.6389 of the shares outstanding. The other top investors are JANUS HENDERSON GROUP PLC which holds 7.38 million shares representing 5.4624 and valued at over $$505.79 million, while STATE STREET CORP holds 2.5779 of the shares totaling 3.49 million with a market value of $$238.99 million.
Globus Medical Inc (GMED) Insider Activity
The most recent transaction is an insider sale by RHOADS ANN D, the company’s Director. SEC filings show that RHOADS ANN D sold 7,500 shares of the company’s common stock on Feb 28 ’25 at a price of $78.68 per share for a total of $0.59 million. Following the sale, the insider now owns 35384.0 shares.
Still, SEC filings show that on Jan 10 ’25, Pfeil Keith W (COO, CFO) disposed off 14,167 shares at an average price of $88.29 for $1.25 million. The insider now directly holds 0 shares of Globus Medical Inc (GMED).
